Arvinas (ARVN) News Today $7.58 +0.18 (+2.43%) Closing price 04:00 PM EasternExtended Trading$7.34 -0.24 (-3.10%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Arvinas, Inc. (NASDAQ:ARVN) Shares Acquired by Kennedy Capital Management LLCKennedy Capital Management LLC boosted its holdings in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 42.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 208,992 shares of the company's stock after acquiring an additional 61,802 shares during theApril 15 at 6:02 AM | marketbeat.comTruist Financial Lowers Arvinas (NASDAQ:ARVN) Price Target to $21.00April 12 at 3:07 AM | americanbankingnews.comTruist Financial Issues Pessimistic Forecast for Arvinas (NASDAQ:ARVN) Stock PriceTruist Financial decreased their price objective on Arvinas from $65.00 to $21.00 and set a "buy" rating for the company in a report on Wednesday.April 11, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Roche Holding (OtherRHHBY) and Arvinas Holding Company (ARVN)April 9, 2025 | markets.businessinsider.comArvinas, Inc. (ARVN): Among Stocks Under $10 that Will TripleApril 9, 2025 | msn.comHC Wainwright Reaffirms Buy Rating for Arvinas (NASDAQ:ARVN)HC Wainwright reissued a "buy" rating and issued a $81.00 target price on shares of Arvinas in a research report on Monday.April 9, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 472,225 Shares of Arvinas, Inc. (NASDAQ:ARVN)JPMorgan Chase & Co. lowered its holdings in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 20.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,857,078 shares of the company's stock after selling 472,225April 9, 2025 | marketbeat.comVanguard Group Inc. Grows Position in Arvinas, Inc. (NASDAQ:ARVN)Vanguard Group Inc. raised its holdings in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 0.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 7,062,561 shares of the company's stock after purchasing an additional 56,561 shares during the period.April 9, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Receives $35.50 Average PT from BrokeragesApril 9, 2025 | americanbankingnews.comArvinas' (ARVN) "Buy" Rating Reaffirmed at HC WainwrightApril 9, 2025 | americanbankingnews.comArvinas price target lowered to $24 from $67 at Piper SandlerApril 8, 2025 | markets.businessinsider.comGuggenheim Keeps Their Buy Rating on Arvinas Holding Company (ARVN)April 8, 2025 | markets.businessinsider.comFinepoint Capital LP Has $13.68 Million Position in Arvinas, Inc. (NASDAQ:ARVN)Finepoint Capital LP raised its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 24.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 713,778 shares of the company's stock after purchasing an additiApril 8, 2025 | marketbeat.comNorges Bank Makes New Investment in Arvinas, Inc. (NASDAQ:ARVN)Norges Bank bought a new position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,243,868 shares of the company's stock, valued at approximately $23,845,000. NorgesApril 8, 2025 | marketbeat.comAmerican Century Companies Inc. Has $4.84 Million Position in Arvinas, Inc. (NASDAQ:ARVN)American Century Companies Inc. lessened its holdings in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 18.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 252,685 shares of the company's stock after selApril 7, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Given Consensus Recommendation of "Moderate Buy" by AnalystsArvinas, Inc. (NASDAQ:ARVN - Get Free Report) has been given an average rating of "Moderate Buy" by the fifteen ratings firms that are covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The avApril 7, 2025 | marketbeat.comArvinas Potential Parkinson's Treatment Shows Positive Data In Human StudyApril 4, 2025 | benzinga.comArvinas Holding Company Unveils Promising ARV-102 Trial ResultsApril 4, 2025 | tipranks.comArvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 DegradationApril 4, 2025 | globenewswire.comEdmond DE Rothschild Holding S.A. Takes Position in Arvinas, Inc. (NASDAQ:ARVN)Edmond DE Rothschild Holding S.A. bought a new position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 80,000 shares of the company's stock,April 3, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: HilleVax, Inc (HLVX), Lexicon Pharmaceuticals (LXRX) and Arvinas Holding Company (ARVN)April 2, 2025 | markets.businessinsider.comShort Interest in Arvinas, Inc. (NASDAQ:ARVN) Decreases By 29.9%Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 8,900,000 shares, a decline of 29.9% from the February 28th total of 12,700,000 shares. Based on an average trading volume of 1,680,000 shares, the short-interest ratio is currently 5.3 days. Approximately 13.7% of the shares of the company are sold short.March 30, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Reaches New 52-Week Low - Here's What HappenedArvinas (NASDAQ:ARVN) Hits New 12-Month Low - Should You Sell?March 28, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Shares Acquired by BIT Capital GmbHBIT Capital GmbH increased its holdings in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 291.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 263,527 shares of the company's stock after purchasing an additional 196March 28, 2025 | marketbeat.comArvinas Announces Oral Presentation at 2025 International Conference on Alzheimer’s & Parkinson’s DiseasesMarch 27, 2025 | finance.yahoo.comArvinas Announces Oral Presentation at 2025 International Conference on Alzheimer's & Parkinson's DiseasesMarch 27, 2025 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Arcutis Biotherapeutics (ARQT)March 25, 2025 | markets.businessinsider.comArvinas (NASDAQ:ARVN) Shares Down 5.1% - What's Next?Arvinas (NASDAQ:ARVN) Shares Down 5.1% - What's Next?March 22, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Trading 4% Higher - Here's What HappenedArvinas (NASDAQ:ARVN) Shares Up 4% - Time to Buy?March 21, 2025 | marketbeat.comCantor Fitzgerald Increases Earnings Estimates for ArvinasArvinas, Inc. (NASDAQ:ARVN - Free Report) - Cantor Fitzgerald boosted their FY2025 earnings per share (EPS) estimates for Arvinas in a research report issued to clients and investors on Tuesday, March 18th. Cantor Fitzgerald analyst L. Watsek now expects that the company will post earnings per shMarch 21, 2025 | marketbeat.comInsider Selling: Arvinas, Inc. (NASDAQ:ARVN) Insider Sells 8,658 Shares of StockArvinas, Inc. (NASDAQ:ARVN - Get Free Report) insider Noah Berkowitz sold 8,658 shares of the company's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $8.59, for a total transaction of $74,372.22. Following the completion of the sale, the insider now directly owns 110,023 shares in the company, valued at $945,097.57. This represents a 7.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.March 20, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Insider Sells $74,372.22 in StockMarch 20, 2025 | insidertrades.comIs Arvinas, Inc. (ARVN) a Pump and Dump Stock Favored by Hedge Funds?March 18, 2025 | insidermonkey.comWedbush Issues Positive Outlook for Arvinas EarningsArvinas, Inc. (NASDAQ:ARVN - Free Report) - Investment analysts at Wedbush upped their Q1 2025 earnings per share (EPS) estimates for shares of Arvinas in a report issued on Wednesday, March 12th. Wedbush analyst R. Driscoll now expects that the company will post earnings of ($0.76) per share forMarch 18, 2025 | marketbeat.comResearch Analysts Issue Forecasts for Arvinas Q1 EarningsArvinas, Inc. (NASDAQ:ARVN - Free Report) - Wedbush boosted their Q1 2025 earnings per share estimates for Arvinas in a research note issued on Wednesday, March 12th. Wedbush analyst R. Driscoll now expects that the company will post earnings of ($0.76) per share for the quarter, up from their prMarch 17, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Given New $12.00 Price Target at Morgan StanleyMorgan Stanley reduced their price target on shares of Arvinas from $48.00 to $12.00 and set an "equal weight" rating on the stock in a research report on Thursday.March 14, 2025 | marketbeat.comGuggenheim Issues Pessimistic Forecast for Arvinas (NASDAQ:ARVN) Stock PriceGuggenheim cut their price objective on Arvinas from $57.00 to $32.00 and set a "buy" rating for the company in a research report on Thursday.March 14, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Downgraded to Neutral Rating by The Goldman Sachs GroupThe Goldman Sachs Group lowered Arvinas from a "buy" rating to a "neutral" rating and reduced their target price for the company from $70.00 to $15.00 in a report on Thursday.March 14, 2025 | marketbeat.comArvinas (ARVN) Moves 8.8% Higher: Will This Strength Last?March 13, 2025 | uk.finance.yahoo.comArvinas (NASDAQ:ARVN) Sees Strong Trading Volume - Here's What HappenedArvinas (NASDAQ:ARVN) Sees Strong Trading Volume - Should You Buy?March 13, 2025 | marketbeat.comWedbush Downgrades Arvinas (ARVN)March 13, 2025 | msn.comArvinas price target lowered to $12 from $48 at Morgan StanleyMarch 13, 2025 | markets.businessinsider.comArvinas price target lowered to $32 from $57 at GuggenheimMarch 13, 2025 | markets.businessinsider.comBank of America Has Lowered Expectations for Arvinas (NASDAQ:ARVN) Stock PriceBank of America dropped their price objective on Arvinas from $54.00 to $28.00 and set a "buy" rating for the company in a report on Wednesday.March 13, 2025 | marketbeat.comArvinas Holding Company (ARVN) Receives a Buy from GuggenheimMarch 13, 2025 | markets.businessinsider.comARVN Stock Plunges 53% Following Mixed Data From Breast Cancer StudyMarch 13, 2025 | finance.yahoo.comArvinas (NASDAQ:ARVN) Receives "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $81.00 price target on shares of Arvinas in a report on Tuesday.March 12, 2025 | marketbeat.comOppenheimer Downgrades Arvinas (NASDAQ:ARVN) to Market PerformOppenheimer lowered Arvinas from an "outperform" rating to a "market perform" rating in a research report on Tuesday.March 12, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Hits New 12-Month Low - Here's WhyArvinas (NASDAQ:ARVN) Reaches New 12-Month Low - Should You Sell?March 12, 2025 | marketbeat.comArvinas Holding Company (ARVN) Receives a Buy from Truist FinancialMarch 12, 2025 | markets.businessinsider.com Remove Ads Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address ARVN Media Mentions By Week ARVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARVN News Sentiment▼0.610.80▲Average Medical News Sentiment ARVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARVN Articles This Week▼156▲ARVN Articles Average Week Remove Ads Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MIRM News Today SDGR News Today DNLI News Today MTSR News Today BHVN News Today TARS News Today BLTE News Today NAMS News Today AAPG News Today JANX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARVN) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arvinas, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arvinas With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARVN Stock Free ARVN Stock Alerts